125 related articles for article (PubMed ID: 91806)
41. [Our experiences in treating patients with Hodgkin disease in the last decade].
Simon Z; Keresztes K; Miltényi Z; Ress Z; Váróczy L; Vadász G; Gergely L; Illés A
Orv Hetil; 2007 Apr; 148(15):675-82. PubMed ID: 17416575
[TBL] [Abstract][Full Text] [Related]
42. A new combination chemotherapy for recurrent Hodgkin's lymphoma.
Rahim MA; Sarma SK; Ahmed Q
Bangladesh Med Res Counc Bull; 1982 Dec; 8(2):63-7. PubMed ID: 6897860
[TBL] [Abstract][Full Text] [Related]
43. The treatment of stage IIIA Hodgkin's disease.
Lister TA; Dorreen MS; Faux M; Jones AE; Wrigley PF
J Clin Oncol; 1983 Dec; 1(12):745-9. PubMed ID: 6689424
[TBL] [Abstract][Full Text] [Related]
44. Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy.
Hagemeister FB; Purugganan R; Fuller L; McLaughlin P; Swan F; Romaguera J; Rodriguez M; Cabanillas F
Semin Hematol; 1994 Apr; 31(2 Suppl 3):36-43. PubMed ID: 8073308
[No Abstract] [Full Text] [Related]
45. [Controversy regarding the treatment of Hodgkin's disease].
Balwierz W; Armata J
Pol Tyg Lek; 1989 Apr; 44(14):315-9. PubMed ID: 2482966
[No Abstract] [Full Text] [Related]
46. Results of a randomized trial comparing MVPP chemotherapy with a hybrid regimen, ChlVPP/EVA, in the initial treatment of Hodgkin's disease.
Radford JA; Crowther D; Rohatiner AZ; Ryder WD; Gupta RK; Oza A; Deakin DP; Arnott S; Wilkinson PM; James RD
J Clin Oncol; 1995 Sep; 13(9):2379-85. PubMed ID: 7666097
[TBL] [Abstract][Full Text] [Related]
47. Five years' experience with ChlVPP: effective low-toxicity combination chemotherapy for Hodgkin's disease.
Dady PJ; McElwain TJ; Austin DE; Barrett A; Peckham MJ
Br J Cancer; 1982 Jun; 45(6):851-9. PubMed ID: 7093120
[TBL] [Abstract][Full Text] [Related]
48. Combination chemotherapy in generalized Hodgkin's disease.
Nicholson WM; Beard ME; Crowther D; Stansfeld AG; Vartan CP; Malpas JS; Fairley GH; Scott RB
Br Med J; 1970 Jul; 3(5713):7-10. PubMed ID: 5427500
[TBL] [Abstract][Full Text] [Related]
49. [Chemotherapy-selective nodal irradiation in Hodgkin's disease clinical stages IA-IIIB. Results of a prospective clinical trial including 334 patients (author's transl)].
Andrieu JM; Asselain B; Bayle C; Teillet F; Clot P; Dana M; Katz M; Brière J; Jacquillat C; Bernard J
Bull Cancer; 1981; 68(2):190-9. PubMed ID: 7016225
[No Abstract] [Full Text] [Related]
50. Free-from-failure survival in Hodgkin's disease. Long-term analysis of 148 cases treated with a MOPP-modified protocol.
Silingardi V; Federico M; Frassoldati A; Barbieri F; Palomba G; Mauri C
Acta Haematol; 1989; 82(4):179-86. PubMed ID: 2511719
[TBL] [Abstract][Full Text] [Related]
51. The effects of prior radiation therapy and age on the frequency and duration of complete remission among various four-drug treatments for advanced Hodgkin's disease.
Cooper MR; Pajak TF; Gottlieb AJ; Glicksman AS; Nissen N; Richards F; Bloomfield C; Holland JF
J Clin Oncol; 1984 Jul; 2(7):748-55. PubMed ID: 6376718
[TBL] [Abstract][Full Text] [Related]
52. [MVPP multiple drug therapy combined with conventional radiotherapy in children with Hodgkin's disease].
Armata J; Stopyrowa J; Depowski M; Strzeszyński J; Borkowski W; Kaczor Z; Depowska T
Pediatr Pol; 1978 May; 53(5):571-7. PubMed ID: 683750
[No Abstract] [Full Text] [Related]
53. A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease.
McElwain TJ; Toy J; Smith E; Peckham MJ; Austin DE
Br J Cancer; 1977 Aug; 36(2):276-80. PubMed ID: 911666
[TBL] [Abstract][Full Text] [Related]
54. The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease.
Whitehead E; Shalet SM; Blackledge G; Todd I; Crowther D; Beardwell CG
Cancer; 1983 Sep; 52(6):988-93. PubMed ID: 6411321
[TBL] [Abstract][Full Text] [Related]
55. [Hodgkin's disease. Study of 100 cases].
Sans-Sabrafen J; Pedro Olivé C; Buxó Costa J; Pardo Peret P; Rodríguez Ferrera JC; Woessner S; Galofré M; Rodríguez Méndez F
Med Clin (Barc); 1987 Feb; 88(5):175-8. PubMed ID: 3561046
[No Abstract] [Full Text] [Related]
56. Long-term follow-up of survival in Hodgkin's lymphoma.
Canellos GP; Niedzwiecki D; Johnson JL
N Engl J Med; 2009 Dec; 361(24):2390-1. PubMed ID: 20007568
[No Abstract] [Full Text] [Related]
57. [Function of the lungs in patients with Hodgkin's disease after chemotherapy and radiotherapy].
Milanowski A; Kulus M; Matysiak M; Ochocka M
Pediatr Pol; 1988 Nov; 63(11):747-52. PubMed ID: 2473435
[No Abstract] [Full Text] [Related]
58. [Controversial aspects in the current treatment of Hodgkin's disease].
Vicente J
Rev Clin Esp; 1987 Feb; 180(3):158-64. PubMed ID: 2437622
[No Abstract] [Full Text] [Related]
59. Alternating drug combinations in the treatment of advanced Hodgkin's disease.
Santoro A; Bonadonna G; Bonfante V; Valagussa P
N Engl J Med; 1982 Apr; 306(13):770-5. PubMed ID: 6174865
[TBL] [Abstract][Full Text] [Related]
60. Pediatric Hodgkin's disease.
Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM
J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
